Wichita Community Clcl Onco Program

Wichita, Kansas 67214

1 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia - Chronic Phase, Lupus Nephritis

Studies at this site

• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V — Recruiting now
• Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling